'Organ preservation' diaporamas de présentation

Everett E. Vokes, MD Director, Section of Hematology/Oncology

Challenging Cases in Cancer: Integration of Findings from ASCO 2007 into Clinical Practice Head & Neck Cancer. Everett E. Vokes, MD Director, Section of Hematology/Oncology Vice-Chairman for Clinical Research, Department of Medicine Deputy Director, Cancer Research Center

999 views • 78 slides

Marshall R. Posner, MD Dana-Farber Cancer Institute

New Paradigms to Improve Outcomes in Head and Neck Cancer The Evolving Roles of Induction Chemotherapy, Chemoradiotherapy, and Sequential Therapy. Marshall R. Posner, MD Dana-Farber Cancer Institute. Case 1: T3N1 Supraglottic Tumor No Significant Co-Morbidities. Patient is a 56 year old male

855 views • 67 slides

Minimal Invasive Renal Surgery

Minimal Invasive Renal Surgery. Dr Dennis Gyomber MB BS, FRACS (Urol) Urological Surgeon University of Melbourne, Department of Surgery, Austin Hospital Austin Hospital , Urology Unit MELBOURNE AUSTRALIA. Overview. Justification for partial nephrectomy Organ preservation

515 views • 39 slides

Neoadjuvant Chemotherapy in Locally Advanced Squamous Cell Cancer of Head and Neck

Neoadjuvant Chemotherapy in Locally Advanced Squamous Cell Cancer of Head and Neck. Mei Tang, MD. Head and Neck Cancer. Worldwide New cases : 644,000 Cancer deaths: 350,000 About 5% of all cancers Local Recurrence: 40% - 60% Distant metastatic disease: 20 - 30%. SCCHN.

637 views • 31 slides

Management of ca larynx & post laryngectomy voice rehabilitation

Management of ca larynx & post laryngectomy voice rehabilitation. Dr. Sheetal Rai Asst. Professor Dept of ENT, YMC. Specific learning objectives. Outline the steps in the diagnosis of laryngeal cancer Outline the treatment options for laryngeal cancer

1.69k views • 30 slides

Perf t oran : Russian Experience

Perf t oran : Russian Experience. Maria Irwin, MD , PhD Clinical Assistant Professor Department of Anesthesiology Congenital Heart Center University of Florida. History 1. 1984-85 first clinical trials (> than 600 patients) Trial and research stopped

321 views • 30 slides

286 views • 17 slides

Organ Preservation Market

Global Organ Preservation Market was valued US$ XX Bn in 2018 and is expected to reach US$ XX Bn by 2026, at 8.7% CAGR of around during a forecast period.

60 views • 5 slides

Organ Preservation Market Research Report Segmentation

Organ Preservation Market Research Report Segmentation, Key Players, Current Growth, Trends, Outlook and Forecast

58 views • 5 slides

Jan. 1987-Dec. 2006, n=89 M : F=58 : 31 Stage III : IV=38 : 51 Primary treatment

Overall survival according to initial treatment modality in locally advanced oral cancer(SqCC, Stage III/IV). Primary Op. RT. CCRT. Induction Chemo. P =.01. T stage 3,4. Primary Op. RT. CCRT. Induction Chemo. P >.05. Jan. 1987-Dec. 2006, n=89 M : F=58 : 31 Stage III : IV=38 : 51

173 views • 3 slides

Organ Preservation Market 2019

Organ Preservation Market Research Report u2013 Forecast to 2023

35 views • 3 slides

25 views • 2 slides

Organ Preservation Market 2019

Organ Preservation Market Research Report u2013 Forecast to 2023

23 views • 2 slides